Compare LGO & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGO | HYFT |
|---|---|---|
| Founded | 1988 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.8M | 80.8M |
| IPO Year | 2007 | 2017 |
| Metric | LGO | HYFT |
|---|---|---|
| Price | $0.95 | $1.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.30 | N/A |
| AVG Volume (30 Days) | ★ 377.3K | 371.0K |
| Earning Date | 11-12-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $111,884,000.00 | $19,019,110.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $53.91 | $71.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 49.46 |
| 52 Week Low | $0.85 | $0.27 |
| 52 Week High | $2.70 | $3.25 |
| Indicator | LGO | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | N/A |
| Support Level | $0.88 | N/A |
| Resistance Level | $1.11 | N/A |
| Average True Range (ATR) | 0.07 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 26.98 | 0.00 |
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.